By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cisbio will distribute Multispan's cell line portfolio in the US, under an agreement announced today by the firms.

The deal covers Multispan's cell line platform of more than 320 human and 209 rodent expression-ready cDNAs and 240 stable cell lines. The cell lines express G-protein coupled receptors in their native forms and "enable comprehensive investigation of effects of drug candidates on downstream signaling of each GPCR," the firms said in a joint statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.